Softgel API Stability via pH Control and Anhydrous Alcohol
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Softgels experience API instability due to adverse reactions between the shell and fill material, leading to degradation of active pharmaceutical ingredients like phenylephrine, which affects shelf-life and effectiveness.
Innovation Solution
The use of acidic solutions and antioxidants in the fill material composition, specifically controlling the pH below the pKa of degradants and incorporating potassium iodide, to inhibit interactions between phenylephrine and degradants of povidone and polyethylene glycol, thereby stabilizing the API.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Stability of the object's composition
If water is included in the softgel shell, then the shell can maintain flexibility and structure, but water can migrate into the fill material causing API degradation
Solution Approach 1:
The patent introduces anhydrous alcohol as an intermediary substance in the fill material that acts as a water scavenger. This mediator binds water molecules through hydrogen bonding, preventing water migration from the shell to the API, thus resolving the contradiction between maintaining shell structure and preventing API degradation.
Solution Approach 2:
The patent changes the chemical environment parameters of the fill material by adding anhydrous alcohol and adjusting pH levels. This parameter change creates a water-binding environment that prevents water migration, allowing the shell to maintain its water-containing structure without causing API degradation.
2Reliability
If antioxidants are added to the fill material, then API stability is improved, but the composition complexity increases
Solution Approach 1:
The patent uses parameter changes by adjusting pH levels and alcohol content to create an environment that inherently protects the API from oxidation. This approach achieves API stability through environmental control rather than adding multiple antioxidant additives, thus improving reliability while minimizing composition complexity.
3Reliability
If pH is controlled below pKa of degradants, then API stability is improved, but the manufacturing precision requirements increase
Solution Approach 1:
The patent employs self-service by using the anhydrous alcohol and other fill material components to naturally buffer and maintain the pH below the pKa of degradants. This self-regulating system reduces the need for precise external pH control during manufacturing, achieving API stability while lowering manufacturing precision requirements.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly improves the stability and shelf-life of phenylephrine and other APIs by minimizing degradation, maintaining the acidic environment within the softgel and reducing the formation of harmful degradants.
Implementation Method 1
controlling the pH of the fill material below the pKa of one or more degradant materials can improve the API stability of the softgel
Implementation Method 2
The use of acidic solutions and antioxidants in the fill material composition, specifically controlling the pH below the pKa of degradants and incorporating potassium iodide, to inhibit interactions between phenylephrine and degradants of povidone and polyethylene glycol
Data Source
AI summary
Softgels having improved stability of active pharmaceutical ingredients and methods of preparing the same are provided. In some embodiments, a softgel comprises a fill material composition and a softgel shell. In some embodiments, the fill material composition of the softgel comprises one or more active pharmaceutical ingredient (API); 2 to 15 wt. % povidone; 30 to 60 wt. % polyethylene glycol; and 0.5 to 5 wt. % propylene glycol, wherein the fill material composition has a pH of 3.75 or less. In some embodiments, the softgel shell is made from a softgel shell composition comprising an acidic component.


